UNSPSC 85444902: The diagnosis of vitamin B12 , folic acid and anti-megaloblastic-anaemia preparations

In this classification, this covers the group of activities that yields a diagnosis of vitamin B 12, folic acid and other anti-megaloblastic-anaemia preparations. Vitamin B 12, folic acid and other anti-megaloblastic-anaemia preparations is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y44.1.

UNSPSC 85444902 Diagnosis of vitamin B12, folic acid and anti-megaloblastic-anaemia preparations (Commodity) shows a mismatch between its nominal scope and the recent state and local opportunities posted under it. The recent opportunities do not procure pharmaceuticals or diagnostic preparations; instead, they solicit Diagnostic Imaging PACS implementation, special education contracted services (audiologists, speech therapists, occupational therapists, and related specialists), and temporary health professional staffing across multiple ancillary clinical categories including audiology, cardiology, diagnostic imaging, and therapy services. The issuing bodies include a county public hospital system (San Mateo Medical Center), a school district (Birdville Independent School District), and a county health system (Santa Clara Health System). This code currently reports little activity relevant to its stated pharmaceutical and laboratory diagnostic scope.

Geographic activity spans California (San Mateo County and Santa Clara County) and Texas (Tarrant County). The three most recent postings occurred between July and October 2026, with response deadlines of October 7, October 21, and October 21, 2026 respectively. None of the recent opportunities—San Mateo Medical Center's PACS solicitation (RFP, due October 21, 2026), Birdville ISD's special education services procurement (sealed proposals, due October 21, 2026), and Santa Clara Health System's temporary health professional staffing pool (non-exclusive multiple-award RFQ, due October 7, 2026)—purchases vitamin B12 preparations, folic acid supplements, or anti-megaloblastic-anaemia medications. The code appears to be incorrectly tagged by the issuing bodies or the opportunity aggregation system; state and local procurement professionals should verify the actual commodity code alignment before pursuing opportunities listed under this code.